There's a second vaccine in the works: Cervarix, from GlaxoSmithKline. Cervarix targets two HPV strains, HPV-16 and HPV-18. GSK says it plans to seek FDA approval for Cervarix by the end of the year.

The next HPV vaccine approved in the United States, called Cervarix, is a bivalent vaccine that protects against HPV types 16 and 18 and was approved for use in females ages 9 to 26. Gardasil 9 ...

The HPV vaccines neutralize type-specific HPV infections ... and DNA-negative at baseline regardless of sexual activity. Cervarix: population analyzed in this table were seronegative to HPV ...

Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually ...

U.S. health officials have expanded the recommended age range for people receiving the HPV vaccine to protect against several types of cancer to people in their mid-40s. MSK physicians offers advice ...

The HPV vaccine made its debut in the early 2000s. The inaugural vaccine, Gardasil, was pioneered by Merck & Co. and gained ...

Cervarix, approved for women aged nine to ... "They're much more effective than many of the vaccines we use," said Money. HPV vaccines are usually offered to school-aged boys and girls, ideally ...

Nearly 90 per cent of cases of cervical cancer are caused by the human papillomavirus (HPV), which spreads primarily through ...

The vaccine is typically given in a series of two doses 6 to 12 months apart for kids or teenagers, and three doses over the course of six months for adults and people who are immunocompromised.

This would broaden the use of HPV vaccines to infected women and potentially ... negative at baseline regardless of sexual activity. Cervarix: population analyzed in this table were seronegative ...